0% found this document useful (0 votes)
56 views8 pages

Pharmaceutical Brochure

Uploaded by

py1174260
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
56 views8 pages

Pharmaceutical Brochure

Uploaded by

py1174260
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 8

PHARMACEUTICAL

r : i::: INDUSTRY IN UP
INVESTORS SUMMrr 2018
21-22 February

/'
SCENARIO IN INDIA
The Indian pharmaceutical industry is robust and thriving. The industry has witnessed robust growth,
registering a growth of 29% in FY 2015-16.

Indian pharmaceutical 2nd largest market in Asia, By 2020 India is expected to


market is the 3rd largest accounts for nearly 3% of b e 6 t h l a rge st m a r ke t
by vo l u m e , a n d 1 3 t h the global pharmaceutical globally
largest by value industry by value

I n d ia exports 20% of India is one of the top 20


global generics, making it global medical device
the largest provider of markets and the 4th largest
generic medicines globally medical device market in Asia

Profit After Tax of Indian Drugs & Pharmaceutical Industry (in INR Crores)

Source: Annual Plan (2016-17), Department of Pharmaceu cals, Ministry of Chemicals & Fer lizers
The Indian Pharmaceutical sector is largely fuelled by exports and is the 3rd largest foreign exchange earner
for India. In 2015-16, the exports of Drugs, Pharmaceuticals and Fine Chemicals amounted to INR 1,09,770
Crores in India. India exports medicines to nearly more than 220 nations across the globe.

Pharmaceu cal Exports from India - Category wise (INR Cr)


Category FY-15 FY-16
Ayush 769.99 706.94
Bulk Drugs & Drug Intermediates 23,169 23,302.8
Drug Formulations & Biologicals 72,892.04 82,192
Herbal Products 1,536.65 1,618
Surgicals 1,946.15 1,950
Total 1,00,313.83 1,09,769.74
Source : India Bulk Manufacturing Associa on of India

100% FDI has been allowed through automatic route for Greenfield pharmaceuticals projects, and 74% FDI
has been allowed through automatic route for Brownfield pharma projects making the Pharmaceutical
industry as the most attractive sector for investments. The sector attracted FDI worth INR 77.631 Cr between
April 2000 and June 2017, which was 4% of total FDI inflows in India.
ADVANTAGE UTTAR PRADESH
Uttar Pradesh is access to country’s 4th largest state, and 3rd largest economy. Home to 16.5% of India’s
population, Uttar Pradesh is amongst the top 5 manufacturing states and has 2nd highest number of MSME
units. 13.26% growth in exports (CAGR) recorded in the state in last 5 years (2012-17). With the highest
population among all Indian states, Uttar Pradesh offers to be the biggest market for pharmaceuticals.

a. Infrastructure Advantage

Location Advantage
Ÿ Located on Golden Quadrilateral with excellent road network
Ÿ Access to National Capital Region on the west
Ÿ Strategic access to market & resource depth of eastern India
Ÿ Largest railway network in the country spanning over 8,949 km

Connectivity
Ÿ Major national & international airports connecting the rest of India,
Middle East & South East Asian countries.
Ÿ Two upcoming international airports at Jewar & Kushinagar
Ÿ Proposed NW-1 connecting Allahabad to Haldia port

Industrial Corridors
Ÿ 8.5% of DMIC catchment area and 57% of AKIC in UP
Ÿ Intersection of WDFC and EDFC at Greater Noida
Ÿ Multi-modal logistic hubs, industrial parks etc. to benefit from reduced
travel time to ports

The existing logistics infrastructure in Uttar Pradesh includes Moradabad rail linked combined domestic and
EXIM terminal, Rail linked Pvt Freight Terminal and Inland Container Depot in Kanpur, ICD at Dadri Terminal,
ICD at Kanpur etc. Besides these, multi modal logistics/ transport hubs are also proposed at Noida, Boraki and
Varanasi.
The connectivity web of the state including existing and upcoming expressways like Poorvanchal Expressway,
Bundelkhand Expressway, Lucknow- Agra Expressway etc.; 4 lane and 6 lane state highways; national and
international airports; NW 1 waterways connecting Allahabad, Varanasi and Haldia sea port etc., is expected
to create a web of air, water, road and rail network that will help the state’s industries and manufacturing
units. The Multi-city metro rail projects, coming up at Lucknow, Kanpur, Meerut and Varanasi, and upcoming
international airport at Jewar and Kushinagar are also expected strength to State’s connectivity advantage.
b. Raw Material base and growing Industry
The State has 2nd highest number of MSME’s in the country and has a considerable chemical and medicinal
raw material base. There are several pharmaceutical units in the State, of which majority are into formulation,
mostly located in the Western region of the state in Ghaziabad, Gautambuddha Nagar, and in Lucknow,
Kanpur.

Exports of Pharmaceu cal Products from U ar Pradesh


2015 -16 INR 363 .42 Crores
2016 -17 INR 519.23 Crores
Source: Department of Export Promo on, Govt of U ar Pradesh

Ÿ Uttar Pradesh has nearly 17% market share of national sale in terms of value, with a turnover of about INR
90,000 crore in pharma sector (2014-15).
Ÿ There are about 76000 pharmacists and 71,000 retail pharmacies in U.P.
The industrial panorama in the state is encouraging and reflects potential for considerable growth in the
pharma sector.

c. Availability of Labour and Strong R&D base


The State has perennial supply of skilled and unskilled manpower and prestigious research institutes and
Department of Pharmaceutics. The Abdul Kalam Technical University of Uttar Pradesh has 100 colleges
providing B.Pharm degree and 64 colleges providing M.Pharm degree.
Uttar Pradesh is home to the prestigious research institutes including -
Ÿ CSIR-Central Drug Research Institute, Lucknow
Ÿ National Institute of Pharmaceutical Education and Research, Raibareli
Ÿ Indian Institute of Toxicology Research (IITR), Lucknow
Ÿ Central Institute of Medicinal and Aromatic Plants, Lucknow
Ÿ National Botanical Research Institute, Lucknow
Ÿ Biological Sciences and Bioengineering Department, IIT- Kanpur
Ÿ Biotechnology Department, MNNIT-Allahabad
Ÿ Indian Institute of Technology – Banaras Hindu University (IIT BHU)
Ÿ King George’s Medical University, Lucknow
Ÿ Sanjay Gandhi Post Graduation Institute of Medical Sciences, Lucknow
KEY INVESTMENT OPPORTUNITIES
1. Manufacturing Bulk Drugs and Generic Medicine: Uttar Pradesh offers the largest consumer base for
domestic consumption and is well connected major ports of India making it for export oriented
production
2. Distribution – Uttar Pradesh is the 4th largest state with population density of 829 people per sq.km.
There is immense scope for development of a drug mechanism for distribution of all kinds of drugs.
3. Wellness drugs- As the industry is progressing and expanding coping up technological advances, there is
scope for production and distribution of wellness drugs.
4. Education & Skill Development - The State offers largest workforce with 56% of the population in
working age group. Home to premier research institutes and education centres in the sector, State is
expanding its education and skill development ecosystem to meet the needs of the industry.
5. Research and Development
Ÿ Drug Testing Technology
Ÿ Contract Research and Manufacturing Services (CRAMS)
Ÿ Biologics and Biosimilars
Ÿ AYUSH and Phytomedicine
6. Manufacturing Medical Devices - With new hospitals and nursing houses coming up and renovation of
existing facilities, manufacturing medical devices in Uttar Pradesh is a promising opportunity.
Contact : Execu ve Director
Udyog Bandhu

12-C, Mall Avenue, Lucknow-226001 (U.P.)


Phone No.: +91-522-2237582/83
Fax No.: +91-522-2237345
Email: info@udyogbandhu.com
www.udyogbandhu.com

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy